Dapsone
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia (NCT02627417) | Assistance Publique - Hôpitaux de Paris | 2015-12-01 |
Track Dapsone automatically
Every clearance here is in the API, with alerts when new ones post.